List of Excipients in API lisinopril and hydrochlorothiazide tablets
✉ Email this page to a colleague
Excipients in ANDA-approved (generic) drugs containing lisinopril and hydrochlorothiazide tablets
Detailed excipient profiles for lisinopril and hydrochlorothiazide tablets
Excipient focus: ANHYDROUS DIBASIC CALCIUM PHOSPHATE
lisinopril and hydrochlorothiazide tablets drug variants containing ANHYDROUS DIBASIC CALCIUM PHOSPHATE
lisinopril and hydrochlorothiazide tablets drug variants not containing ANHYDROUS DIBASIC CALCIUM PHOSPHATE
Excipient focus: CALCIUM PHOSPHATE, DIBASIC, DIHYDRATE
lisinopril and hydrochlorothiazide tablets drug variants containing CALCIUM PHOSPHATE, DIBASIC, DIHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| A-S Medication Solutions | lisinopril and hydrochlorothiazide tablets | 50090-7294 |
| >Company | >Ingredient | >NDC |
lisinopril and hydrochlorothiazide tablets drug variants not containing CALCIUM PHOSPHATE, DIBASIC, DIHYDRATE
Excipient focus: DIBASIC CALCIUM PHOSPHATE DIHYDRATE
lisinopril and hydrochlorothiazide tablets drug variants containing DIBASIC CALCIUM PHOSPHATE DIHYDRATE
lisinopril and hydrochlorothiazide tablets drug variants not containing DIBASIC CALCIUM PHOSPHATE DIHYDRATE
Excipient focus: FERRIC OXIDE RED
lisinopril and hydrochlorothiazide tablets drug variants containing FERRIC OXIDE RED
lisinopril and hydrochlorothiazide tablets drug variants not containing FERRIC OXIDE RED
Excipient focus: FERRIC OXIDE YELLOW
lisinopril and hydrochlorothiazide tablets drug variants containing FERRIC OXIDE YELLOW
lisinopril and hydrochlorothiazide tablets drug variants not containing FERRIC OXIDE YELLOW
Excipient focus: HEMATITE
lisinopril and hydrochlorothiazide tablets drug variants containing HEMATITE
| Company | Ingredient | NDC |
|---|---|---|
| A-S Medication Solutions | lisinopril and hydrochlorothiazide tablets | 50090-7294 |
| >Company | >Ingredient | >NDC |
lisinopril and hydrochlorothiazide tablets drug variants not containing HEMATITE
Excipient focus: MAGNESIUM STEARATE
lisinopril and hydrochlorothiazide tablets drug variants containing MAGNESIUM STEARATE
lisinopril and hydrochlorothiazide tablets drug variants not containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: MANNITOL
lisinopril and hydrochlorothiazide tablets drug variants containing MANNITOL
lisinopril and hydrochlorothiazide tablets drug variants not containing MANNITOL
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: STARCH, CORN
lisinopril and hydrochlorothiazide tablets drug variants containing STARCH, CORN
lisinopril and hydrochlorothiazide tablets drug variants not containing STARCH, CORN
| Company | Ingredient | NDC |
|---|---|---|
| A-S Medication Solutions | lisinopril and hydrochlorothiazide tablets | 50090-7294 |
| >Company | >Ingredient | >NDC |
Excipient focus: ZEA MAYS
lisinopril and hydrochlorothiazide tablets drug variants containing ZEA MAYS
| Company | Ingredient | NDC |
|---|---|---|
| A-S Medication Solutions | lisinopril and hydrochlorothiazide tablets | 50090-7294 |
| >Company | >Ingredient | >NDC |
lisinopril and hydrochlorothiazide tablets drug variants not containing ZEA MAYS
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2026 - 2027
NCE-1 Patent Challenge Dates 2026 - 2027
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2026, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch